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Abstract. Plant cell and organ cultures constitute a promising 
platform for the production of numerous valuable secondary 
compounds. Currently, in vitro culture techniques involve both 
empirical and rational approaches as suitable strategies to condition 
high metabolite production and establish competitive plant cell-based 
bioprocesses. In this context, we have developed hairy root cultures of 
Panax ginseng, and engineered hairy root cultures of Duboisia, 
Datura metel and Hyoscyamus spp and plant cell cultures of Centella 
asiatica and Taxus spp. This chapter describes our work on the 
development of two different biotechnological systems to improve 
taxol production in cell suspension cultures of Taxus spp and 
ginsenoside production in hairy root cultures of Panax ginseng. 
 
Introduction 
 
 Plant secondary metabolites play an important role in plant defense and 
constitute a source of phytochemicals for human health and nutrition. The 
three main groups of plant secondary metabolites (alkaloids, polyphenols 
 
Correspondence/Reprint request: Dr. Mercedes Bonfill, Department of Plant Physiology, Faculty of Pharmacy, 
Barcelona University, Avda Joan XXIII s/n, Barcelona, Spain. E-mail: mbonfill@ub.edu 
Mercedes Bonfill et al. 34 
and terpenes) include a wide range of compounds with high added value. 
Some of them can be synthesized chemically, but due to their highly 
complex structures most are extracted from the plant. However, sometimes 
even extraction from the plant is not feasible, due to low production levels, 
and the risk of endangering the species. 
 In vitro culture techniques using plant cell and organ cultures are 
promising tools for the production of numerous valuable secondary 
compounds. Empirical approaches have long been employed for the 
development and optimization of plant cell-based bioprocesses, focusing on 
input (cell line, medium, culture parameters, bioreactors, process operations, 
etc.) and output factors (cell growth, nutrient uptake, productivity, yield, 
etc.). In addition, a rational approach, taking into account the molecular and 
cellular basis of metabolic pathways and their regulation, is currently being 
used. The successful biotechnological production of phytochemicals with 
high added value, such as the anticancer compound taxol, shows that plant 
cell and organ cultures can constitute an alternative to the culture of the 
whole plant for the production of secondary metabolites with biological 
activity [1].  
 The biotechnological production of plant secondary metabolites has 
several advantages over the culture of the whole plant in the field, including:  
 
• The desired product can be harvested anywhere in the world, maintaining 
strict control of production and quality. 
• It is not necessary to use herbicides and pesticides. 
• Climate or ecological problems are avoided. 
• Growth cycles are of weeks rather than years.  
 
 Our research is based on plant in vitro culture and genetic and metabolic 
engineering techniques with the aim of increasing the production of high-
value phytochemicals and obtaining plant stem cells for cosmetic uses             
(Fig. 1). Working with plant in vitro cultures, we are interested in the 
selection of highly productive genotypes and the micropropagation of 
aromatic and medicinal plants in order to maintain the most productive ones 
and, in cases of endangered plants, to help preserve the species. Plant 
micropropagation also represents the best way to obtain virus-free plants to 
meet phytosanitary requirements for plant import-export. Another goal is 
using plant cells and hairy root cultures for the production of 
phytochemicals. 
 Another field of our research involves the application of genetic and 
metabolic engineering techniques to improve the production of target 
secondary metabolites. In this case, it is necessary to understand the relevant 
biosynthetic pathways and to know which enzymes catalyze the sequence of  
Plant cell and organ cultures as a source of phytochemicals 35 
 
 
Figure 1. Plant in vitro culture and genetic and metabolic engineering techniques as 
the basis of Plant Biotechnology. 
 
reactions, especially the slow steps, and the genes encoding these enzymes. 
Using the aforementioned techniques, the plant secondary pathways are 
studied to detect the flux-limiting steps and improve production. 
 In this chapter, we will describe the different in vitro techniques being 
used in our laboratory, with relevant examples of the plant species we have 
studied. Finally, we will describe our work on the development of a 
biotechnological system to increase taxol and taxane production using Taxus 
baccata and T. media cell suspension cultures and ginsenoside production in 
hairy root cultures of Panax ginseng. 
 
1. Plant in vitro cultures 
 
Micropropagation of aromatic and medicinal plants 
 
 Micropropagation is a way of obtaining a large number of plants in vitro 
in an asexual manner, ensuring that they are genetically and phenotypically 
identical to the original plant. It consists of the culture of variably sized plant 
pieces using a suitable culture medium. In this field, our group has 
developed specific protocols to micropropagate Lavandula dentata [2], 
Ruscus aculeatus [3], etc. Recently our work has focused on the 
micropropagation of Centella asiatica using synthetic seeds and obtaining 
several virus-free varieties of Vitis vinifera plants for exportation (Fig. 2). 
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Figure 2. Our Background in Micropropagation. 
 
Plant cell factories and stem cells 
 
 Plant cell factories constitute a biotechnological platform for the 
production of phytochemicals. In this way, cell cultures, also known as 
plant stem cells, can be utilized as cell suspensions or immobilized cells. 
Plant stem cells have an unlimited capacity for growth and an ability to 
produce identical new plants. By means of in vitro culture techniques, we 
are able to obtain plant stem cells with the same biosynthetic capacity as 
the whole plant. To establish a cell suspension culture that can act as a 
plant cell factory, it is first necessary to obtain a high callus biomass.  
 The methodology employed (Fig. 3) involves the following steps: 
selection of highly productive genotypes of the target plant; induction of 
calli from the best explant to obtain callus biomass; disintegration of calli 
by shaking in a liquid medium to obtain cell suspension cultures; 
optimization of the culture conditions by assaying several basic media, 
plant growth regulators (PGRs), sugar supplements, addition of elicitors, 
precursors, etc. to improve the production; and finally, scale-up to 
bioreactor level. Sometimes immobilization in alginate beads may be 
necessary to improve the biotechnological production [4]. 
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Figure 3. Plant cell factories: methodology 
 
 Regarding the development of plant biofactories, our group is working 
on centelloside production in cell suspension cultures of Centella asiatica 
[5]. We are also working on ruscogenin production in Ruscus aculeatus and 
podophyllotoxin production in Linum album, but our main research line is 
focused on the biotechnological production of taxol and taxanes in cell 
suspension cultures of Taxus baccata and T.media [6, 7]. We have 
previously developed cell cultures for the production of digoxin, digitoxin, 
tobacco alkaloids and galphimines. 
 We have also recently obtained plant stem cells of Vitis vinifera and 
Centella asiatica for cosmetic uses. C.asiatica was traditionally used in 
Ayurveda medicine and due to its dermatological applications, its stem cells 
are currently an important target for cosmetic purposes in Europe. 
 
Plant biotransformations 
 
 Another cell culture application is biotransformation. In this context, 
we have established a single protocol for extracting -amyrin from copal 
resin, which is then added as a substrate to cell suspension cultures of                
C. asiatica for its bioconversion into compounds with high added value, 
such as centellosides [8]. The results have demonstrated that cell lines are 
capable of biotransforming a compound with low biological activity but 
that is abundant in nature, such as amyrin, into other compounds widely 
used for their pharmacological properties, such as the centellosides            
(Fig. 4). 
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Figure 4. Biotransformation of the substrate -amyrin into centellosides. 
 
Hairy root cultures 
  
 Sometimes the production of plant secondary metabolites requires 
organized cultures such as roots or aerial shoots. In this context, our group 
uses the Agrobacterium rhizogenes system to genetically transform plant 
cells and develop hairy root cultures. A.rhizogenes is a bacterium that infects 
plants in nature, transferring a part of its plasmidic DNA, the Transfer-DNA 
or T-DNA, to the plant cell. The infected plant then develops large roots 
called hairy roots. Biotechnological processes based on hairy root cultures 
show a very high biomass production and a metabolic profile similar to the 
root of the whole plant. 
 This methodology (Fig. 5) is based on obtaining hairy root lines after 
infection with A.rhizogenes, the isolation and selection of the most 
productive root lines, optimization of culture conditions for maximum 
production and eventual scale-up to bioreactors. The scaling up of these 
cultures is very difficult because bioreactors are generally designed for the 
culture of microorganisms and need to be specially adapted for the culture of 
transformed roots. 
 Our group has worked with hairy root cultures for the production of 
ajmalicine in Catharanthus roseus [9], ginsenosides in Panax ginseng [10], 
tropane alkaloids in Datura metel, Duboisia sp and Hyoscyamus sp. [11,12], 
withanolides in Withania coagulans [13] and lately we have also been 
working on transformed root cultures of Linum album for the production of 
podophyllotoxin and methoxypodophyllotoxin [14]. 
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Figure 5. Hairy root cultures of Catharanthus roseus scaled up to airlift bioreactor 
level. 
  
2. Genetic and metabolic engineering techniques 
 
 To improve the biotechnological production of a secondary metabolite, 
it is necessary to understand the relevant biosynthetic pathways. It is also 
necessary to know which enzymes catalyze the sequence of reactions, 
especially the slow steps, and the genes encoding these enzymes. Using 
genetic and metabolic engineering techniques, we can study the plant 
secondary pathways to detect the flux-limiting steps in the biosynthesis of 
phytochemicals and use engineering techniques to design plants and cell 
cultures with improved production. 
 We have used metabolic engineering techniques to improve the 
production of scopolamine in the species Datura metel, Hyoscyamus muticus 
and a Duboisia hybrid. The first step was to obtain hairy root cultures of the 
aforementioned species and then select the most productive ones to be scaled 
up to bioreactor level (Fig. 6). 
 The second step was the overexpression, both separately and together, of 
the genes encoding the enzymes putrescine methyltransferase (PMT), which 
constitutes the first committed step in the scopolamine biosynthesis, and 
hyoscyamine 6- -hydroxylase (H6H), which transforms hyoscyamine into 
scopolamine [15]. The best results were obtained by overexpressing both 
genes together in transformed roots of H. muticus (Fig. 7). 
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Figure 6. 1st step: Obtaining hairy root cultures of a Duboisia hybrid and scaling up 
to wave bioreactor level. 
 
 
 
Figure 7. 2nd step: Overexpression of putrescine methyltransferase and hyoscyamine 
6- -hydroxylase. 
 
 Thirdly, since scopolamine is an alkaloid of greater commercial interest 
than the more naturally abundant hyoscyamine, we developed a 
biotechnological system to biotransform exogenous hyoscyamine into 
scopolamine based on tobacco transformed roots carrying the hyoscyamine 
6- -hydroxylase gene of H. muticus (Fig. 8). 
 In addition, with the aim of scaling up the system and avoiding the 
problems of root cultures in bioreactors, we dedifferentiated the roots and 
established cell suspensions that were also able to biotransform hyoscyamine 
into scopolamine at a bioreactor level [16]. 
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Figure 8. 3rd step: Biotransformation of hyoscyamine into scopolamine in tobacco 
hairy root cultures. 
 
 
 
Figure 9. Improving secondary metabolite production using empirical and rational 
approaches.  
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 To sum up, to improve secondary metabolite production using in vitro 
cultures one can consider two principal approaches (Fig. 9).  An empirical 
strategy involves the modification of input factors, such as the selection of 
more productive cell lines, optimizing culture media, the use of elicitor 
treatments, bioreactor design, etc. However, this does not provide 
information about what is happening in the producer cells at the molecular 
level. By taking a rational approach based on genetic and metabolic 
engineering techniques, we can study how the input factors change the 
metabolic and transcriptomic profile of the target cell cultures. 
 
3. Improving taxol and taxane production in cell suspension 
cultures of Taxus sp. 
 
 For some time now, one aspect of our research work has been focused 
on taxol production using cell cultures of different Taxus species. Taxol, a 
diterpene alkaloid with a very complex chemical structure, is one of the most 
effective anticancer drugs ever developed. It presents a unique mode of 
action on the microtubular cell system by inhibiting cell proliferation at the 
G2 phase of the cell cycle, thus blocking mitosis. 
 The natural source of taxol is the inner bark of several Taxus species. 
The disadvantages of this source are that taxol accumulates at a very low 
concentration (0.02% of dry weight), its extraction involves the destruction 
of yew trees and is very expensive. Moreover, the endangered status of 
several Taxus species excludes this method of obtaining taxol. For these 
reasons, alternative sources of taxol have been assayed, including its 
preparation by total synthesis, but this process is not commercially viable. 
Another possibility is producing taxol semisynthetically from more abundant 
taxanes, for example, via the conversion of baccatin III found in Taxus 
needles, but the cost and difficulty of the extraction and purification process 
of these precursors are also very high. An alternative consists of cultivating 
Taxus trees in the field. In fact, in Yunnan province in China, there are 
conventional Taxus crops for the production of taxol, but a harvest can only 
be obtained after several years and the extraction remains very expensive 
[17]. Therefore, the most promising approach to a sustainable commercial 
production of taxol, or other compounds synthesized by plants in similarly 
small quantities, is provided by plant cell cultures.  
 In order to obtain cell suspensions, first on a small scale and then at 
bioreactor level, it is necessary to establish fast-growing callus cultures from 
which the cell suspensions are derived. Taxus callus cultures were obtained 
from young stems of 3-4-year-old yew trees cultured in optimum conditions. 
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Figure 10 shows the whole process until the establishment of a small-scale 
cell suspension culture. 
 To develop a biotechnological system for a high taxol production, it is 
necessary to optimize the culture conditions by assaying several basic media, 
plant growth regulators, sugar supplements etc., which requires knowledge 
of the growth curves of the system. A growth curve represents the biomass 
production (growth) in relation to the time of culture, and appears as a 
sigmoid curve with 3 characteristic phases: 1) A lag phase in which the 
biomass does not increase, when cells are preparing all the machinery for the 
cell division that will start in the exponential phase. 2) An exponential phase 
in which cells are dividing continuously by mitosis. All the processes related 
with mitosis, which are part of the plant’s primary metabolism, are now 
taking place inside the cells, including DNA duplication, and RNA and 
protein synthesis. In these conditions secondary metabolism is inhibited. 3) 
A stationary phase in which the biomass of the system remains constant and 
the number of cells that divide by mitosis is almost equal to the number of 
dying cells. In these conditions, the cells can accumulate precursors for the 
biosynthesis of phytochemicals and the machinery of plant secondary 
metabolism begins to work. 
 
 
 
Figure 10. Establishment of Taxus cell suspension cultures. 
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 Once the growth curve of a culture is established, we know how long 
each phase is and when the stationary phase begins, which is the moment 
for adding precursors, elicitors, permeabilizing agents etc. to improve the 
production. Knowledge of the growth curve is particularly useful in a two-
stage culture, that is, when a separate medium is required to enhance 
growth and another to increase production. In this case, during                             
the exponential phase the cells are cultured in the growth medium and      
then transferred to the production medium at the start of the stationary 
phase. 
 A two-stage culture system was established for taxol production. Plant 
cells were first cultured in a medium optimised for their growth, which 
was then replaced by a production medium that mainly stimulates the 
biosynthesis of secondary metabolites. This system has an added 
advantage of permitting the addition of biosynthetic precursors and 
elicitors in the production medium.  
 In summary, taxol and baccatin III production was clearly enhanced by 
the transfer of cells from the growth to the production medium containing 
the elicitor methyl jasmonate (MeJA) [18]. After optimizing the culture 
conditions, we scaled up the culture in a stirred bioreactor where the 
production improved 2.4-fold for taxol and 9-fold for baccatin III.  
  
 
 
Figure 11. Taxol production in immobilized cell cultures of Taxus baccata in a 
stirred bioreactor. 
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 We continued our study on the improvement of taxol and related taxane 
production by establishing immobilized cell cultures, first on a small scale 
and then at bioreactor level. Numerous studies have reported that 
immobilization of plant cell suspensions enhances the production of valuable 
plant metabolites. Taxol production clearly improved when cell suspensions 
were immobilised in 2% alginate beads and cultured in a stirred bioreactor, 
using the optimum medium for the biosynthesis of taxol. When the taxol 
production was at its highest, on day 16, its levels were more than 5-fold 
higher than those obtained by the same cell line growing freely in the same 
conditions (Fig. 11). The novelty of this work was to demonstrate that 
immobilization strongly constrains the physiology of T.  baccata cells and 
substantially enhances taxane production in bioreactor cultures [4]. 
 
4. Ginsenoside production in hairy root cultures of Panax 
ginseng 
 
 Ginsenosides are triterpenes with a great variety of properties, being 
used as tonics, analgesics, antipyretics, stress-beaters, etc. 
   
 
 
Figure 12. Improving ginsenoside production in hairy root cultures of Panax 
ginseng. 
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 Hairy root cultures were obtained using the following protocol. After 
infection of the rhizome with A. rhizogenes, we obtained hairy roots that 
were cultured in a solid growth medium and their transformed nature was 
confirmed. The transformed roots were then transferred to a liquid medium 
to optimize growth and production, using elicitors, precursors and beta-
sitosterol. Finally, we scaled up the culture by assaying different types of 
bioreactors, optimizing the culture conditions. A two-stage system was not 
used in this case. Figure 12 summarizes the whole process. 
 After the infection of the rizome with A. rhizogenes we obtained roots 
with 3 types of morphology: 50% had a typical hairy root morphology (HR-
M), 35% a callus morphology (C-M) and 15% a thin morphology (T-M) 
[19]. The transformed nature of each type of root was confirmed by 
amplifying the rol C gene. The highest growth in solid medium was 
displayed by C-M roots, although the total ginsenoside content was higher in 
T-M roots, albeit lower than in the plant rhizome. 
 After transferring the roots from the solid to the liquid medium to 
optimize the growth and production, the best growth was achieved by the             
C-M roots, followed by the HR-M roots, as occurred in the solid medium. It 
should be emphasized that all the roots grew better in liquid medium. 
 Regarding the ginsenoside production, the best results were obtained 
with HR-M roots in liquid medium, in contrast with the solid medium where 
the best production was obtained with T-M roots. 
  We then optimized the culture conditions by assaying several elicitors 
(chitosan, methyl jasmonate, vanadyl sulfate), precursors (mevalonic acid, 
squalene, farnesol) and beta-sitosterol (which bioregulates the synthesis of 
ginsenosides). The best result was obtained with MeJA, which increased the 
production of ginsenosides in all the root types [20]. The precursors and 
beta-sitosterol did not yield any significant results. Compared with a 4-year-
old Panax ginseng plant rhizome, the ginsenoside production of a 
transformed HR-M root grown in liquid medium with MeJA for 4 weeks 
was almost 2-fold higher. 
  Finally, we optimized the process at a bioreactor level. We first selected 
the most productive hairy root line (HR-M), which was cultured in the liquid 
medium optimized on a small scale in 3 types of bioreactors: airlift, spray 
and wave. After 28 days of culture without changing the medium, the best 
growth was obtained in the wave bioreactor, but the best ginsenoside 
production was achieved in the spray bioreactor. However, if we determine 
the productivity, that is, the ginsenoside production per liter and per day, the 
best results were obtained with the wave bioreactor in the same culture 
conditions: after 28 days without changing the media. This confirms that the 
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productivity of a culture does not only depend on the accumulation of the 
target compound but also on its growth capacity. 
 In summary, after 28 days of culture without changing the media, we 
obtained the best production in a spray bioreactor but the best productivity in 
a wave bioreactor. Optimum growth was also obtained in the wave 
bioreactor. 
 We next determined the biomass and ginsenoside production in 2 
bioreactors (spray and wave) after 28 days of culture but this time changing 
the culture medium at day 15. In these conditions, the biomass production 
increased in both bioreactors, and was therefore higher in the wave 
bioreactor. Regarding the ginsenoside production, the results again showed 
more production in the spray bioreactor, but when we determined the 
productivity, the roots in the wave bioreactor were the most productive, as 
before.  
 Finally, we cultured the roots (HR-M) in the two bioreactors (spray 
and wave) but now for 56 days and changing the medium every 15 days 
[21]. The highest productivity of the roots was again achieved in the                  
wave bioreactor, being almost 2-fold higher than in the small flasks              
(Fig. 13). 
  
 
  
Figure 13. Ginsenoside productivity of typical hairy roots (HR-M) grown in small 
flasks, spray and wave bioreactors on a 56-day culture with change of media every 15 
days. 
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5. Conclusion 
 
 We have established two biotechnological systems (cell suspension cultures 
of Taxus sp. and hairy roots of Panax ginseng) to improve the production of two 
high-value target compounds (taxol and ginsenosides) using an empirical 
approach that considers input and output factors (Fig. 9). Taxol production was 
improved employing a two-stage culture system, elicitation with MeJA, 
immobilization in alginate beds and scaling up in a stirred bioreactor. 
Ginsenoside production was improved using selected hairy root lines of three 
different morphologies, elicitation with MeJA, changing the medium during the 
culture, assaying three bioreactor designs and taking into account production and 
productivity. These results can be improved in future studies taking a rational 
approach. 
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